Overview:
Oncology nurses are pivotal members of the healthcare teams in managing these new and complex therapies. Their role in patient monitoring, education, and intervention is essential for successful treatment with ADCs. Nurses are uniquely positioned to identify early signs of toxicities, educate patients on possible adverse events, and help mitigate those risks via early medical intervention.
However, many nurses have not received comprehensive education on the relevant biomarkers of ADCs, their mechanism of action, and adverse event management. Given the rapid introduction of ADCs into the clinical landscape, it is critical to address these gaps through continuing education programs. This educational symposium targeted to oncology nurses will help bridge these gaps, enabling nurses to provide better patient care and improve clinical outcomes.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Discuss the role of ADC therapeutic targets in solid tumors
- Interpret findings from recent clinical trials on ADC therapies and their implications for advanced practice providers
- Apply evidence-based strategies to monitor and manage ADC-specific adverse events during and after treatment
- Describe clinical considerations of ADC therapy needed to effectively counsel patients
Michelle L. Taylor, ANP-BC
Breast Oncology Nurse Practitioner
Wendt Family Breast Cancer Program
Dignity Health Cancer Institute at St. Joseph’s Hospital and Medical Center
Phoenix, AZ
Beth Sandy, MSN, CRNP, FAPO
Thoracic Oncology Nurse Practitioner
Abramson Cancer Center
Hospital of the University of Pennsylvania
Philadelphia, PA
Emely Alfaro, DNP, RN, CNS, OCN
Assistant Clinical Professor
UCSF School of Nursing
University of California, San Francisco
Clinical Nurse Specialist, Outpatient Adult Oncology
Adult Infusion Services
San Francisco, CA
Paige Griffith, CRNP
Solid Tumor Advanced Practice Provider Manager
GI Oncology Nurse Practitioner
Skip Viragh Outpatient Cancer Center
The Sidney Kimmel Comprehensive Cancer Center
The Johns Hopkins Hospital
Baltimore, MD
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC (PER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Physicians' Education Resource®, LLC has approved this knowledge-based activity for 1.50 ACPE CE hours, UAN # 0661-0000-25-017-L01-P. Eligibility for credits requires full attendance, engagement in the live activity, completion and submission of the learner NABP ID # and month and day of birth, activity pre- and post-session questions, and the post activity evaluation. This UAN # expires February 28, 2027.